Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia

Brian S. White; Suleiman A. Khan; Mike J. Mason; Muhammad Ammad-ud-din; Swapnil Potdar; Disha Malani; Heikki Kuusanmäki; Brian J. Druker; Caroline Heckman; Olli Kallioniemi; Stephen E. Kurtz; Kimmo Porkka; Cristina E. Tognon; Jeffrey W. Tyner; Tero Aittokallio; Krister Wennerberg; Justin Guinney

doi:10.1038/s41698-021-00209-9

Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia

Brian S. White, Suleiman A. Khan, Mike J. Mason, Muhammad Ammad-ud-din, Swapnil Potdar, Disha Malani, Heikki Kuusanmäki, Brian J. Druker, Caroline Heckman, Olli Kallioniemi, Stephen E. Kurtz, Kimmo Porkka, Cristina E. Tognon, Jeffrey W. Tyner, Tero Aittokallio, Krister Wennerberg, Justin Guinney

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Artikkeli	71
Lehti	npj precision oncology
Vuosikerta	5
Numero	1
Sivumäärä	11
DOI - pysyväislinkit	https://doi.org/10.1038/s41698-021-00209-9
Tila	Julkaistu - 23 heinäk. 2021
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3122 Syöpätaudit

Pääsy asiakirjaan

10.1038/s41698-021-00209-9

s41698-021-00209-9Lopullinen julkaistu versio, 1,93 MBLisenssi: CC BY

Siteeraa tätä

White, B. S., Khan, S. A., Mason, M. J., Ammad-ud-din, M., Potdar, S., Malani, D., Kuusanmäki, H., Druker, B. J., Heckman, C., Kallioniemi, O., Kurtz, S. E., Porkka, K., Tognon, C. E., Tyner, J. W., Aittokallio, T., Wennerberg, K., & Guinney, J. (2021). Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia. npj precision oncology, 5(1), Artikkeli 71. https://doi.org/10.1038/s41698-021-00209-9

@article{db23407990154e2f81a1e9ae43a4e5a0,

title = "Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia",

keywords = "DRUG RESPONSE CONSISTENCY, R PACKAGE, CANCER, SENSITIVITY, APOPTOSIS, CELLS, REGULARIZATION, IDENTIFICATION, INDUCTION, MECHANISM, 3122 Cancers",

author = "White, {Brian S.} and Khan, {Suleiman A.} and Mason, {Mike J.} and Muhammad Ammad-ud-din and Swapnil Potdar and Disha Malani and Heikki Kuusanm{\"a}ki and Druker, {Brian J.} and Caroline Heckman and Olli Kallioniemi and Kurtz, {Stephen E.} and Kimmo Porkka and Tognon, {Cristina E.} and Tyner, {Jeffrey W.} and Tero Aittokallio and Krister Wennerberg and Justin Guinney",

year = "2021",

month = jul,

day = "23",

doi = "10.1038/s41698-021-00209-9",

language = "English",

volume = "5",

journal = "npj precision oncology",

issn = "2397-768X",

publisher = "Springer",

number = "1",

}

White, BS, Khan, SA, Mason, MJ, Ammad-ud-din, M, Potdar, S, Malani, D, Kuusanmäki, H, Druker, BJ, Heckman, C , Kallioniemi, O, Kurtz, SE, Porkka, K, Tognon, CE, Tyner, JW, Aittokallio, T, Wennerberg, K & Guinney, J 2021, 'Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia', npj precision oncology, Vuosikerta 5, Nro 1, 71. https://doi.org/10.1038/s41698-021-00209-9

TY - JOUR

T1 - Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia

AU - White, Brian S.

AU - Khan, Suleiman A.

AU - Mason, Mike J.

AU - Ammad-ud-din, Muhammad

AU - Potdar, Swapnil

AU - Malani, Disha

AU - Kuusanmäki, Heikki

AU - Druker, Brian J.

AU - Heckman, Caroline

AU - Kallioniemi, Olli

AU - Kurtz, Stephen E.

AU - Porkka, Kimmo

AU - Tognon, Cristina E.

AU - Tyner, Jeffrey W.

AU - Aittokallio, Tero

AU - Wennerberg, Krister

AU - Guinney, Justin

PY - 2021/7/23

Y1 - 2021/7/23

KW - DRUG RESPONSE CONSISTENCY

KW - R PACKAGE

KW - CANCER

KW - SENSITIVITY

KW - APOPTOSIS

KW - CELLS

KW - REGULARIZATION

KW - IDENTIFICATION

KW - INDUCTION

KW - MECHANISM

KW - 3122 Cancers

U2 - 10.1038/s41698-021-00209-9

DO - 10.1038/s41698-021-00209-9

M3 - Article

SN - 2397-768X

VL - 5

JO - npj precision oncology

JF - npj precision oncology

IS - 1

M1 - 71

ER -